Abstract
Transition from detention to the community for Black men who have sex with men with criminal justice involvement (BMSM-CJI) represents a particularly vulnerable period for HIV acquisition and transmission. We examined levels of HIV PrEP awareness among BMSM-CJI. PrEP awareness among BMSM-CJI was low (7.9%) with evidence of lower awareness levels among those with STI. There was evidence that HIV testing history was associated with higher PrEP awareness. Study findings highlight needs for further assessment of PrEP knowledge among BMSM-CJI. The strong association between HIV testing and PrEP awareness underscores an opportunity to integrate PrEP education within HIV/STI testing services
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Data contain protected health information and are therefore not available for review.
Code Availability
Coding for the analysis in the report is available from the primary author.
References
Brewer, R. A., Magnus, M., Kuo, I., Wang, L., Liu, T. Y., & Mayer, K. H. (2014a). Exploring the relationship between incarceration and HIV among black men who have sex with men in the United States. Journal of Acquired Immune Deficiency Syndromes, 65(2), 218–225. https://doi.org/10.1097/01.qai.0000434953.65620.3d
Brewer, R. A., Magnus, M., Kuo, I., Wang, L., Liu, T. Y., & Mayer, K. H. (2014b). The high prevalence of incarceration history among Black men who have sex with men in the United States: Associations and implications. American Journal of Public Health, 104(3), 448–454. https://doi.org/10.2105/ajph.2013.301786
Centers for Disease Control & Prevention. (2019a). PrEP | HIV Basics | HIV/AIDS | CDC. Retrieved from https://www.cdc.gov/hiv/basics/prep.html
Centers for Disease Control & Prevention. (2019b). Preventing new HIV infections | Guidelines and Recommendations | HIV/AIDS | CDC. Retrieved from https://www.cdc.gov/hiv/guidelines/preventing.html
Centers for Disease Control & Prevention. (2020). HIV and African American gay and bisexual men | HIV by Group | HIV/AIDS | CDC. Retrieved from https://www.cdc.gov/hiv/group/msm/bmsm.html
Epperson, M. W., El-Bassel, N., Chang, M., & Gilbert, L. (2010). Examining the temporal relationship between criminal justice involvement and sexual risk behaviors among drug-involved men. Journal of Urban Health, 87(2), 324–336.
Grant, R., Lama, J., Anderson, P., McMahan, V., Liu, A., Vargas, L., & Glidden, D. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.
HIV.gov. (2012). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Retrieved from https://www.hiv.gov/blog/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection
Khan, M. R., Doherty, I. A., Schoenbach, V. J., Taylor, E. M., Epperson, M. W., & Adimora, A. A. (2009). Incarceration and high-risk sex partnerships among men in the United States. Journal of Urban Health, 86(4), 584–601.
Nunn, A. S., Brinkley-Rubinstein, L., Oldenburg, C. E., Mayer, K. H., Mimiaga, M., Patel, R., & Chan, P. A. (2017). Defining the HIV pre-exposure prophylaxis care continuum. AIDS, 31(5), 731–734.
Ricks, J. M., Crosby, R. A., & Terrell, I. (2015). Elevated sexual risk behaviors among postincarcerated young African American males in the South. American Journal of Men’s Health, 9(2), 132–138.
Sullivan, P. S., Sanchez, T. H., Zlotorzynska, M., Chandler, C. J., Sineath, R., Kahle, E., & Tregear, S. (2020). National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017. Journal of the International AIDS Society, 23(3), e25461.
Acknowledgements
We are thankful to the following groups who made possible the HPTN 061 study: HPTN 061 study participants; HPTN 061 Protocol co-chairs, Beryl Koblin, PhD, Kenneth Mayer, MD, and Darrell Wheeler, PhD, MPH; HPTN061 Protocol team members; HPTN Black Caucus; HPTN Network Laboratory, Johns Hopkins University School of Medicine; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Statistical and Data Management Center, Statistical Center for HIV/AIDS Research and Prevention; HPTN CORE Operating Center, Family Health International (FHI) 360; Black Gay Research Group; clinical research sites, staff, and Community Advisory Boards at Emory University, Fenway Institute, GWU School of Public Health and Health Services, Harlem Prevention Center, New York Blood Center, San Francisco Department of Public Health, the University of California, Los Angeles, Center for Behavioral and Addiction Medicine, and Cornelius Baker, FHI 360. We are thankful to Sam Griffith, Senior Clinical Research Manager, FHI 360, and Lynda Emel, Associate Director, HPTN Statistical and Data Management Center, Fred Hutchinson Cancer Research Center, for their considerable assistance with HPTN 061 data acquisition and documentation. This research was supported by the National Institute on Drug Abuse grant ‘Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM’ This research uses data from the HIV Prevention Trials Network 061 (HPTN 061) study. HPTN 061 grant support was provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding included Fenway Institute Clinical Research Site (CRS): Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). Authors received support from the New York University Center for Drug Use and HIV Research (P30 DA011041); authors additionally were supported by the New York University-City University of New York (NYU-CUNY) Prevention Research Center (U48 DP005008), the University of Maryland Prevention Research Center (U48 DP006382), and NIMH (R21 MH121187). The funder had a role in the design of the study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript. The funding agencies had no role in designing the research, data analyses and preparation of the report.
Funding
This research was supported by the National Institute on Drug Abuse grant ‘Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM’ This research uses data from the HIV Prevention Trials Network 061 (HPTN 061) study. HPTN 061 grant support was provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding included Fenway Institute Clinical Research Site (CRS): Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). Authors received support from the New York University Center for Drug Use and HIV Research (P30 DA011041); authors additionally were supported by the New York University-City University of New York (NYU-CUNY) Prevention Research Center (U48 DP005008), the University of Maryland Prevention Research Center (U48 DP006382), and NIMH (R21 MH121187). The funder had a role in the design of the study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript. The funding agencies had no role in designing the research, data analyses and preparation of the report.
Author information
Authors and Affiliations
Contributions
JF, MK and RB proposed the original research question. JF conducted analysis and wrote the initial draft of the manuscript. CC assisted with statistical analysis; MK, TD, RT, CHO, CC, JS, LH, KM and RB provided guidance and expertise on subject matter related to the study sample and design, and all authors reviewed the final manuscript prior to submission AIDS and Behavior.
Corresponding author
Ethics declarations
Conflicts of interest
No conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Feelemyer, J.P., Khan, M.R., Dyer, T.V. et al. Pre-Exposure Prophylaxis (PrEP) Awareness Among Black Men Who Have Sex with Men with a History of Criminal Justice Involvement in Six U.S. Cities: Findings from the HPTN 061 Study. Arch Sex Behav 50, 2943–2946 (2021). https://doi.org/10.1007/s10508-021-02010-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-021-02010-y